Navigation Links
Study seeks to widen corneal transplant window

Researchers at Case Western Reserve University School of Medicine will lead a national study determining if corneas transplanted up to two weeks after donor death work as well as corneas transplanted up to one week after donor death. The National Eye Institute has awarded a $12.3 million grant to support the work.

The supply of donated corneas nationwide meets current needs about 40,000 transplants in 2010.

But with an aging population and health concerns about the future donor pool, researchers want to ensure the supply can meet an expected growth in demand over the next two to three decades.

"Over the past 20 years, corneal transplant specialists have gotten comfortable using corneas up to one week after the death of the donor, when in fact they can use them up to two weeks after death," said Dr. Jonathan Lass, the Charles I Thomas Professor and Chairman of the Case Western Reserve Department of Ophthalmology and Visual Sciences and Director of the University Hospitals Eye Institute. Lass, who is also medical director of the Cleveland Eye Bank, which provides corneas for transplant, is the lead investigator of the Cornea Preservation Time Study.

The kickoff meeting for investigators and eye banks participating in the Cornea Preservation Time Study will be held prior to the American Academy of Ophthalmology Convention in Orlando, Friday, Oct. 21 at the Cornea Society/Eye Bank Association of America Fall Symposium.

"The Cornea Preservation Time Study is a model for the type of research we must continue to pursue in order to creatively target critical issues such as donor organ shortages," said Pamela B. Davis, MD PhD, dean of the CWRU School of Medicine.

"This project offers the potential of immediate, life-altering impact for thousands of people."

The U.S. Food and Drug administration does permit corneas to be stored in preservation medium at refrigerator temperature up to two weeks after donor death. And the excess supply of donated corneas in the U.S. about 20 percent annually - are shipped overseas where they are successfully transplanted more than a week after donation.

But there has been limited follow-up.

To convince U.S. corneal surgeons to change from their regular practice, successful transplantation in the second week needs to be proved, Lass said.

The result of doubling the window for corneal transplants will increase the pool of donated corneas and improve public health and safety, he said.

Patients who need corneal transplants are typically 50 and older. According to projections by the U.S. Census Bureau, that population will grow from about 99 million in 2010 to about 133 million by 2030 in this country.

While the number of patients will grow the number of potential donors is waning.

"All of these issues disqualify potential donors: food contamination, such as mad cow disease and the recent listeria outbreak in cantaloupe; the growing number and spread of infectious diseases such as HIV and West Nile virus and the tropical disease chikungunya, which have no cure; high-risk behaviors such as methamphetamine use - which is at epidemic levels in some parts of the country - IV drug use and imprisonment; the growing number of people diagnosed with Alzheimer's or other neurologic diseases of unknown origin; and the aging population itself, which is less suited to donate because corneas age and deteriorate;" explained Dr. Marian Macsai, a professor of ophthalmology at the University of Chicago and chair of the Eye Bank Association of America. "Add them up and you've got a shrinking donor pool."

In addition to fewer donors to rely on, the growing list of disqualifiers requires greater scrutiny of the sources, Lass said. "We need more time to analyze the donor and test blood to ensure the safety of the recipient and quality of the cornea he or she receives."

The five-year study will be conducted at university-based, including University Hospitals Case Medical Center, and private clinics across the U.S. Leading institutions include Case Western Reserve School of Medicine's Vision Research Coordinating Center and Cornea Image Analysis Reading Center, in Cleveland, and the Jaeb Center for Health Research, in Tampa, Fla.

Researchers will compare the outcomes of 1,330 corneal transplants. Half the patients will receive transplants within 7 days of donor death, half within 8 to 14 days.

People suffering from diseases affecting the corneal endothelium, the critical back cell layer of the cornea that keeps the cornea from swelling, including Fuchs' Endothelial Corneal Dystrophy, an age-related disease that may be inherited; and pseudophakic/aphakic corneal edema, a complication following cataract surgery, will be enrolled.

All patients will undergo a corneal transplant called an endothelial keratoplasty. Doctors or the eye bank take a slice from the back of a healthy donated cornea, open a small slit in the patient's eye, scrape out the diseased endothelial cells and replace them with the donor cells.

Doctors will examine patients' transplants over the next three years, to determine if the cornea has remained clear or become clouded due to poor functioning or death of the transplanted cells.

Although results of the study directly apply only to the use of donor corneas used for this specific operation and these conditions, researchers hope that results could be extended to donor corneas used for other types of transplants and other diseases.

In addition to the federal grant, the Eye Bank Association of America, individual eye banks, and the Cornea Society, which represents corneal surgeons, have contributed $315,000 to support the study.


Contact: Kevin Mayhood
Case Western Reserve University

Related biology news :

1. From tropics to poles: Study reveals diversity of life in soils
2. Scripps launches whole genome sequencing study to find root causes of idiopathic diseases
3. Virginia Tech biomedical engineers announce child football helmet study
4. Study identifies molecules used by certain species of seaweed to harm corals
5. UGA study suggests key to avoiding ankle re-injury may be in the hips and knees
6. Genetic study of cave millipedes reveals isolated populations and ancient divergence between species
7. Study shows that new DNA test to identify Down syndrome in pregnancy is ready for clinical use
8. Study shows unexpected effect of climate change on body size for many different species
9. Joslin study finds clue to birth defects in babies of mothers with diabetes
10. First genome-wide association study for dengue identifies candidate susceptibility genes
11. Largest ever genetic study of liver function could point the way to new treatments
Post Your Comments:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/4/2015)... 2015 --> ... by Transparency Market Research "Home Security Solutions Market - Global ... - 2022", the global home security solutions market is expected to ... The market is estimated to expand at a CAGR ... 2022. Rising security needs among customers at homes, the ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... DIEGO , Nov. 24, 2015 Halozyme Therapeutics, Inc. ... Healthcare Conference in New York on Wednesday, ... Helen Torley , president and CEO, will provide a corporate ... New York at 1:00 p.m. ET/10:00 a.m. PT ... and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)...  Clintrax Global, Inc., a worldwide provider of clinical research services ... that the company has set a new quarterly earnings record in ... growth posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , ...
(Date:11/24/2015)... , November 24, 2015 ... market research report released by Transparency Market Research, the ... at a CAGR of 17.5% during the period between ... Market - Global Industry Analysis, Size, Volume, Share, Growth, ... non-invasive prenatal testing market to reach a valuation of ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... InSphero AG, ... 3D cell culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... Aregger served on the management team and was promoted to Head of ...
Breaking Biology Technology: